Atlas Trials

A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

Clinical trial NCT06833853 · RECRUITING

Trial details

NCT number
NCT06833853
Sponsor
Menarini Silicon Biosystems, INC
Status
RECRUITING
Study type
OBSERVATIONAL
Metastatic Breast Cancer (MBC)
Start date
2026-03-13
Primary completion
2028-10-01
Enrollment
187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.